ArticleInternational journal of clinical and experimental pathology2015

The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.

Yaoyang Yu et al.PubMed ↗Full text ↗

No numbers read from the abstract.